We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Results from a phase 3 trial show similar ...

The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a ...

(RTTNews) - Sandoz, Inc., an unit of Novartis Pharma AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high ...

Patients exposed to a higher dose may be subject to bleeding complications. Apotex Corp announced the voluntary recall of 2 batches of Enoxaparin Sodium Injection ...

Princeton, New Jersey, April 25, 2012 – Sandoz today announced the introduction of enoxaparin sodium injection, USP 3 mL vials, a generic version of Sanofi's Lovenox® Injection Multiple-Dose Vials, in ...

Princeton, NJ, Sandoz Inc. (“Sandoz”) is initiating a recall of one lot (SAB06761A, Exp 04/2023) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL Single-Dose Syringes to the consumer level. A portion ...

The results of three studies could usher in a new era of fixed-dose oral thromboprophylaxis. Prophylactic anticoagulation is recommended practice following total knee and hip arthroplasty. Commonly ...

Please provide your email address to receive an email when new articles are posted on . Treatment with rivaroxaban was more effective than enoxaparin for preventing venous thromboembolism during ...

In a significant advancement for emergency care, Jharkhand's health department is introducing life-saving enoxaparin injections in district and medical college hospitals that do not have cardiology ...

CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated generic injectables company today announced the launch of Enoxaparin Sodium Injection, USP, the generic ...